BioCentury
ARTICLE | Clinical News

BGC20-1531: Phase II start

July 21, 2008 7:00 AM UTC

Early next year, BTG will begin a Phase II trial. The company licensed rights to BGC20-1531 from Asterand in 2006 (see BioCentury, Feb. 6, 2006). ...